• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Youtube
  • otv

Tag: Dgci

Covid Vaccine Allocation To Odisha
DGCI Nod For Sanofi-GSK's Phase 3 Trial Of Covid Vax In India

The French pharma company Sanofi and its British peer GSK aim to produce up to one billion doses in 2021.

Biophore Seeks DCGI Approval For Aviptadil For Covid Treatment

Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of Covid-19.

India Studies Post-Vaccination Adverse Events Amid Concerns Over Covishield
DCGI Extends Shelf Life Of Covishield From 6 To 9 Months

New Delhi: India’s drug regulator DCGI has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date. In a letter to the Serum Institute of India, Drugs Controller General of India V G Somani said the SII is permitted to apply the shelf life of nine […]

DCGI Gives Nod To India's First Indigenous mRNA Vaccine For Human Trial

New Delhi: India’s first indigenous mRNA vaccine candidate has received approval from the Drug Controller General of India to initiate Phase I/II human clinical trial, the Ministry of Earth Sciences said on Friday. The novel mRNA vaccine candidate, HGCO19 has been developed by Gennova, a company based in Pune and supported with seed grant under […]